Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90 Y-ibritumomab-tiuxetan.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 02780232 AND DT 2011 AND VI 29 AND IP 3
Results: 14
1
2
Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 116, doi. 10.1002/hon.965
- By:
- Publication type:
- Article
3
Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 157, doi. 10.1002/hon.976
- By:
- Publication type:
- Article
4
Expression of glucocorticoid receptor spliced variants in lymphoma cell lines.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 147, doi. 10.1002/hon.964
- By:
- Publication type:
- Article
5
Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after <sup>90</sup>Y-ibritumomab-tiuxetan.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 131, doi. 10.1002/hon.968
- By:
- Publication type:
- Article
6
Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 161, doi. 10.1002/hon.979
- By:
- Publication type:
- Article
7
In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 164, doi. 10.1002/hon.981
- By:
- Publication type:
- Article
8
Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab-associated late onset neutropenia.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 144, doi. 10.1002/hon.963
- By:
- Publication type:
- Article
9
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 154, doi. 10.1002/hon.974
- By:
- Publication type:
- Article
10
The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patients.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 124, doi. 10.1002/hon.967
- By:
- Publication type:
- Article
11
Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 139, doi. 10.1002/hon.978
- By:
- Publication type:
- Article
12
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 151, doi. 10.1002/hon.966
- By:
- Publication type:
- Article
13
A review of the trends of lymphomas in the equatorial belt of Africa.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. 111, doi. 10.1002/hon.977
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 3, p. i, doi. 10.1002/hon.1016
- Publication type:
- Article